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HIVd cellular proteins to the nucleolus is determined by a variety of factors including
nucleolar localisation signals (NoLSs), but how these signals operate is not clearly understood. The nucleolar
trafﬁcking of wild type viral proteins and chimeric proteins, which contain altered NoLSs, were compared to
investigate the role of NoLSs in dynamic nucleolar trafﬁcking. Three viral proteins from diverse viruses were
selected which localised to the nucleolus; the coronavirus infectious bronchitis virus nucleocapsid (N)
protein, the herpesvirus saimiri ORF57 protein and the HIV-1 Rev protein. The chimeric proteins were N
protein and ORF57 protein which had their own NoLS replaced with those from ORF57 and Rev proteins,
respectively. By analysing the sub-cellular localisation and trafﬁcking of these viral proteins and their
chimeras within and between nucleoli using confocal microscopy and photo-bleaching we show that NoLSs
are responsible for different nucleolar localisations and trafﬁcking rates.
© 2008 Elsevier Inc. All rights reserved.Introduction
The nucleolus is a sub-nuclear compartment involved in many
processes crucial to the efﬁcient functioning of a eukaryotic cell
(Carmo-Fonseca et al., 2000; Lam et al., 2005). These include, but are
not limited to, ribosomal RNA synthesis (Grummt, 2003), modulation
of cell growth (Hernandez-Verdun and Roussel, 2003) and response to
cell stress (Rubbi and Milner, 2003). It is composed of over 700
proteins (Leung et al., 2006) which can be grouped into separate
classes depending on their role in the nucleolus and wider cell
function (Leung et al., 2003; Leung and Lamond, 2003).
The nucleolus is formed from a myriad of protein:protein and
protein:nucleic acid interactions (Carmo-Fonseca, 2002; Louvet et al.,
2005). Several features can be identiﬁed in the nucleolus correspond-
ing to its central role in RNA synthesis including ﬁbrillar centres (FCs),
dense ﬁbrillar components (DFCs), and a granular compartment (GC)
(Louvet et al., 2005). As with other sub-nuclear structures, although
the nucleolus appears to be stable, when viewed as ﬁxed cellCellular Biology, Faculty of
s, LS2 9JT, Leeds, England, UK.
l rights reserved.preparations for ﬂuorescence or under the electron microscope,
nucleolar proteins are undergoing continuous exchange with the
nucleoplasm (Andersen et al., 2005; Hernandez-Verdun, 2006;
Hernandez-Verdun et al., 2002; Lamond and Sleeman, 2003; Phair
and Misteli, 2000). Therefore the structure of the nucleolus has been
proposed to be maintained by the equilibrium between binding and
release of sequestered proteins (Misteli, 2001). As such to account for
protein localisation to discrete compartments within the nucleus
including the nucleolus, a scanning mechanism has been proposed
(Misteli, 2001) in which proteins diffuse through the nucleoplasm
until they ﬁnd their target, rather than requiring speciﬁc targeting
signals per se (Misteli, 2001).
DNA, retro and RNAvirus proteins and in some cases viral genomes
trafﬁc to and from the nucleolus (Hiscox, 2002, 2007). For example, in
the DNA virus herpesvirus saimiri (HVS), nucleolar localization of the
viral ORF57 protein was shown to be required for the nuclear-
cytoplasmic trafﬁcking of intron-less viral RNAs (Boyne and White-
house, 2006; Goodwin et al., 1999; Williams et al., 2005). A number of
retroviral proteins, for example from human immunodeﬁciency virus
(HIV-1), localise to the nucleolus including the Rev (Cochrane et al.,
1990; Perkins et al., 1989) and Tat proteins (Kuppuswamy et al., 1989;
Ruben et al., 1989). One of the functions of Rev protein within the life
cycle of HIV is trafﬁcking of intron-containing viral RNA from the
nucleus to the cytoplasm (Pollard and Malim, 1998). Multimerisation
192 E. Emmott et al. / Virology 380 (2008) 191–202of Rev is crucial to this function (Stauber et al., 1998), and this step is
predominately thought to occur in the nucleolus (Daelemans et al.,
2004). Indeed the interaction of Rev with viral RNA can be disrupted
through the use of nucleolar Rev binding elements (Michienzi et al.,
2006), HIV-1 RNA can be cleaved in the nucleolus using ribozymes
(Michienzi et al., 2000) and likewise small nucleolar RNA-TAR decoy
RNAs can be used to sequester Tat (Michienzi et al., 2002). All of these
approaches have illustrated the essential role of the nucleolus in virus
biology as well as providing potential genetic therapeutic strategies
against HIV-1 infection (Rossi et al., 2007). Despite the cytoplasm
being the primary site of viral RNA synthesis, many positive strand
RNA virus proteins have been shown to localise to the nucleolus
(Hiscox, 2003, 2007; Rowland and Yoo, 2003; Taliansky and Robinson,
2003; Weidman et al., 2003), and these are generally viral capsid/
nucleocapsid proteins whose function is in binding to viral RNA. For
example, many coronavirus and the closely related arterivirus
nucleocapsid (N) proteins have been shown to localise to the
nucleolus (Hiscox et al., 2001; Rowland et al., 1999; Tijms et al.,
2002; Wurm et al., 2001). Mutation of the nuclear/nucleolar
localisation signal (NLS/NoLS) in the arterivirus porcine reproductive
and respiratory syndrome virus (PRRSV) N protein in the context of
recombinant virus infected cells resulted in cytoplasmic localisation of
the protein and lower viral titers when compared to wild type virus
(Lee et al., 2006). Upon passage in swine, NLS/NoLS revertant mutants
were observed (Lee et al., 2006) pointing to a role for the nucleolus/
nucleus in the virus life cycle (Pei et al., 2008). In the positive strand
plant RNA groundnut rosette virus the nucleolus and interaction with
nucleolar proteins has been shown to be essential for systemic
infection (Kim et al., 2007a, 2007b). In negative strand RNAviruses the
nucleoprotein and non-structural protein 1 (NS1) protein in certain
strains of inﬂuenza virus has also been shown to localise to the
nucleolus (Melen et al., 2007; Ozawa et al., 2007), and NS1 protein has
been shown to interact with nucleolin (Murayama et al., 2007).
How viral and cellular proteins trafﬁc to the nucleolus and
what determines their sub-nucleolar localisation is not clearly under-
stood, but NoLSs are thought to be involved (Carmo-Fonseca et al.,
2000). How these operate to direct proteins to the nucleolus is generally
not well understood. To investigate the role of NoLSs in dynamic
trafﬁcking and directing sub-nucleolar localisation, three viral proteins
were selected from a DNA, RNA and retrovirus, which had deﬁned but
different NoLSs. The avian coronavirus, infectious bronchitis virus N
protein, a phosphorylated viral RNA binding protein (Chen et al., 2005;
Spencer et al., 2008; Spencer and Hiscox, 2006), localises to both the
cytoplasm and the nucleolus in both infected and cells over-expressing
N protein (Chen et al., 2002; Hiscox et al., 2001; Wurm et al., 2001). N
protein can be predominately foundwithin the DFC andGC (Dove et al.,
2006; Reed et al., 2006) and contains an eight amino acid motif
(WRRQARFK) which is necessary and sufﬁcient for directing nucleolar
localisation (Reed et al., 2006). N protein also contains a deﬁnednuclear
export signal (Reed et al., 2007). HVS ORF57 protein localises
predominately to the nucleus, nucleolus and nuclear speckles (Good-
win et al., 1999; Williams et al., 2005) and contains a bi-partite NoLS
which is composed of two different but functional NLSs, a classical pat4
motif (KRPR) and a second 10 amino acid motif (RRPSRPFRKP) (Boyne
andWhitehouse, 2006). HIV-1 Rev protein, localises to the nucleolus in
the DFCs and GC (Dundr et al.,1995) and contains a 16 amino acidmotif
(RQARRNRRRRWRERQRQ) which directs nucleolar localisation
(Cochrane et al., 1990; Kubota et al., 1989). All of these signals have
been shown to be necessary (i.e. if they are deleted/mutated in the
context of wild type protein then nucleolar localisation is abolished)
and sufﬁcient (theywill retarget an exogenous protein to the nucleolus)
for protein localisation to the nucleolus (Cochrane et al.,1990; Goodwin
and Whitehouse, 2001; Reed et al., 2006).
In this study nucleolar localisation signals, nucleolar retention
signals, nucleolar accumulation signals are all referred to as NoLSs. By
analysing the trafﬁcking of these three viral proteinswe demonstratedthat each protein had different nucleolar trafﬁcking rates due to their
alternative NoLSs. This was conﬁrmed by swapping the NoLSs
between viral proteins and thereby altering their trafﬁcking dynamics
and localisation.
Results and discussion
Nucleolar localisation of viral proteins
To investigate the role of viral NoLSs in localisation and dynamic
nucleolar trafﬁcking, a series of expression plasmids were utilised
which led to the production of wild type viral proteins tagged to EGFP
(EGFP-N, EGFP-Rev and EGFP-ORF57) (Fig. 1), and chimeric proteins in
which the function of the wild type NoLS had been disabled and
replaced with a heterologous NoLS from another viral protein. These
chimeric proteins were generated from EGFP-N protein in which its
own NoLS had been disrupted (Reed et al., 2006) and replaced with
the corresponding NoLS from ORF57 (generating protein EGFP-
NΔNoLS/ORF57) and the EGFP-ORF57 protein in which its NoLS had
been disrupted and replaced the HIV-1 Rev protein NoLS (generating
protein EGFP-ORF57ΔNoLS/Rev) (Boyne and Whitehouse, 2006) (Fig. 1).
Fluorescent fusion tagged proteins were used in this study to allow
live imaging, dynamic trafﬁcking, to avoid ﬁxation artefacts of sub-
cellular localisation and also difﬁculties associated with using anti-
bodies to detect proteins in the nucleolus (Sheval et al., 2005.
To provide markers for the nucleolus and for comparison in the
dynamic trafﬁcking analysis described below, Vero cells were
transfected with expression plasmids which led to the production of
ﬂuorescent tagged cellular nucleolar proteins, nucleolin (EGFP-
nucleolin), ﬁbrillarin (EGFP-ﬁbrillarin) and one of the two splice
variants of B23 (Chang and Olson, 1989); B23.1 (EGFP-B23.1). EGFP-
nucleolin localised predominately to the nucleolus (with some nuclear
localisation) and was located mainly within the GC, but was excluded
from FCs (Fig. 2). EGFP-ﬁbrillarin had a globular type nucleolar
localisation and localised principally to the DFCs with some nuclear
accumulation (Fig. 2). EGFP-B23.1 localised mainly to the DFCs in the
nucleolus but did not accumulate in the FCs (Fig. 2). This is similar to
previously published data on the nucleolar localisation of these
proteins (Chen and Huang, 2001; Dundr et al., 2000).
The data indicated that in Vero cells EGFP-N protein localised
either to the cytoplasm or the cytoplasm and nucleolus with a small
amount of nuclear localisation (two examples of the latter are shown)
(Fig. 2). EGFP-ORF57 protein localised predominately to the nucleolus
with a variable distribution in the nucleus, and occasionally did not
localise to the nucleolus (Fig. 2). EGFP-Rev protein localised
predominately to the nucleolus (Fig. 2). Whilst EGFP-N protein and
EGFP-Rev protein had a nucleolar distribution which was similar to
EGFP-B23.1, localising to the DFCs, EGFP-ORF57 did not have a
nucleolar localisation pattern which corresponded to the marker
proteins, and could not be assigned either to the FC, DFC or GC.
Previously, Rev protein has been reported to localise to the DFC and GC
and to co-localise with B23.1 (Dundr et al., 1995). Interestingly over-
expression of the viral and chimeric viral proteins led to different
nucleolar morphologies suggesting that these proteins may alter the
structure of the nucleolus. Certainly in both herpes-simplex-virus-1
(Lymberopoulos and Pearson, 2007; Bertrand and Pearson, 2008) and
IBV infected cells (Dove et al. 2006) nucleolar morphology can alter.
In both cases the chimeric proteins also localised to the nucleolus
in Vero cells, with the same apparent distribution as the protein from
which the NoLS had been derived (Fig. 2). EGFP-NΔNoLS/ORF57 localised
predominately to the nucleolus and in some cases had distinct
possible nuclear speckles which are thought to co-localise with
splicing factors (which has previously been observed for ORF57;
Cooper et al., 1999), rather than the nucleolus and cytoplasm observed
with EGFP-N protein. EGFP-ORF57ΔNoLS/Rev preferentially accumu-
lated in the nucleolus over the nucleus and in some cases had an
Fig. 1. Diagrammatic representation of the EGFP-viral wild type and chimeric fusion proteins used in this study. The position and amino acid of each NoLS is indicated and in the
chimeric fusion proteins the inactivated NoLS is denoted in crosshatch. IBV N protein, Rev protein and ORF57 protein are shown in pink, red and blue, respectively. EGFP is denoted in
green.
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data suggests that viral NoLSs can be substituted between viral
proteins whilst still maintaining the phenotype of nucleolar localisa-
tion. However, the heterologous NoLSmay alter the localisationwithin
the nucleolus.
To conﬁrm that the chimeric proteins were able to localise to the
nucleolus and potentially had different localisation patterns to the
parental proteins, these proteins were expressed in Vero cells which
also expressed the appropriate parental proteins fromwhich the NoLS
had been derived. Given that all of the ﬂuorescent proteins used were
EGFP-tagged, two other wild type ﬂuorescent labelled proteins were
generated, EYFP-N and BFP-ORF57, to use in conjunction with the
EGFP-wild type and chimeric proteins. Note that in all images both
EYFP-N protein and BFP-ORF57 protein were false coloured red post
image capture.
First to conﬁrm that both EYFP-N protein and BFP-ORF57 protein
had identical localisation to EGFP-N protein and EGFP-ORF57 protein,
respectively, and thus could be used when comparing the localisation
of the chimeric proteins, these proteins were co-expressed in Vero
cells. Both EGFP-N protein and EYFP-N protein co-localised to the
cytoplasm and the nucleolus as determined by the merged image (Fig.
3A). EGFP-ORF57 protein and BFP-ORF57 protein co-localised as
determined by the merged image (Fig. 3B). In both cases variable
nuclear localisationwas observed and two examples of this are shown
inwhich the proteins appear to bemainly localised to the nucleolus, or
localised to the nucleolus and other sub-nuclear structures (Fig. 3B).
Co-expression of EGFP-N and BFP-ORF57 indicated that whilst EGFP-N
localised in the cytoplasm and the nucleolus, BFP-ORF57 localised in
the nucleolus only (Fig. 3C) as would be predicted based upon their
expression proﬁles when expressed in isolation. In cells expressing
EGFP-Rev protein and BFP-ORF57 protein (Fig. 3D), EGFP-Rev protein
localised predominately to the nucleolus and BFP-ORF57 predomi-
nately to other nuclear structures, with a weaker localisation in thenucleolus. This suggested that when co-expressed, EGFP-Rev protein
may occupy the nucleolus in preference to BFP-ORF57 protein; this
may be related to trafﬁcking dynamics and/or relative afﬁnity of
interaction with components of the nucleolus.
The sub-cellular localisation of the chimeric proteins was then
compared to the wild type protein from which the NoLS was derived.
We predicted that if the identiﬁed NoLS was the sole determinant of
nucleolar localisation then in cells co-expressing EGFP-NΔNoLS/ORF57
protein and EYFP-N protein, EGFP-NΔNoLS/ORF57 protein would localise
to the nucleolus and EYFP-N protein would localise to the cytoplasm
and the nucleolus.When co-expressed inVero cells, EGFP-NΔNoLS/ORF57
protein had the same distribution as when expressed in isolation
(Fig. 4A). However, EYFP-N protein had a localisation pattern that was
predominately nucleolar/nuclear (Fig. 4A), similar to EGFP-NΔNoLS/
ORF57 protein. A minority of the protein still localised to the cytoplasm
but was below the threshold of detection when the ﬂuorescence in
the nucleoluswas captured in the linear range, indicating a localisation
pattern intermediate between ﬂuorescent tagged wild type N protein
and EGFP-NΔNoLS/ORF57 protein. This result may indicate that EGFP-
NΔNoLS/ORF57 protein and EYFP-N protein dimerised and that the
ORF57 NoLS was the dominant localisation signal operating in the
protein complex. Certainly puriﬁed IBV N protein can form multimers
which are linked by disulphide bridge formation (Chen et al., 2003,
2005).
As would be predicted, co-expression of EGFP-NΔNoLS/ORF57 protein
and BFP-ORF57 protein showed identical co-localisation indicating
that the ORF57 NoLS directed both proteins to the same sub-nuclear
structures (Fig. 4B). Co-expression of EGFP-ORF57ΔNoLS/Rev and BFP-
ORF57 indicated that in general both proteins co-localised (Fig. 4C)
(although there were minor differences, arrowed and visible in
merged image), despite the parental EGFP-Rev protein and BFP-
ORF57 protein having different localisation patterns (Fig. 3D). Similar,
to the self-association of N protein, data indicated that ORF57 protein
Fig. 2. Sub-cellular localisation of EGFP-nucleolin, EGFP-ﬁbrillarin and EGFP-B23.1 and EGFP-N, EGFP-Rev, EGFP-ORF57, EGFP-NΔNoLS/ORF57 and EGFP-ORF57ΔNoLS/Rev in Vero cells as
determined by live cell confocal microscopy. The width of the marker is 15 μmand the image encompasses one nucleus. The nucleolus, nucleus and cytoplasm are indicated as No, Nu
and Cyto, respectively.
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therefore account for the co-localisation of EGFP-ORF57ΔNoLS/Rev and
BFP-ORF57, and again indicating that one NoLS might be dominant
over another.
Although Vero cells are permissive for infection with IBV, and thus
may be considered an appropriate model for studying the sub-cellular
localisation of N protein, we also investigated the sub-cellular
localisation of EGFP-N, EGFP-Rev and EGFP-ORF57, EGFP-NΔNoLS/ORF57
and EGFP-ORF57ΔNoLS/Rev and also the cellular nucleolar marker
proteins in cell lines related to the host species of the appropriate
viral protein. This included; the avian cell line Doug Foster 1 (DF-1)
which is permissive for IBV infection, the Owl monkey kidney (OMK)
cellwhich supports the replication ofHVS and thehumanHeLa cell line
which is permissive for HIV-1 infection (provided the appropriate
receptor is exogenously expressed) (Supplementary data). In all cases
EGFP-nucleolin, EGFP-ﬁbrillarin and EGFP-B23.1 localised to the
nucleolus. In DF-1 and Vero cells EGFP-N protein localised to either
to the cytoplasm or the cytoplasm and the nucleolus with approxi-
mately a 50% frequency for each phenotype, in line with that
previously observed for this cell type (Cawood et al., 2007). In
approximately 90% of OMK and HeLa cells EGFP-N protein localised
to the cytoplasm only, while in approximately 10% of these cells
localisationwas both cytoplasmic and nucleolar. In contrast, in all four
cell types (e.g. Vero, DF-1, OMK and HeLa cells) EGFP-ORF57 displayed
variable nuclear localisation; nucleolar, nuclear and nucleolar, nuclear
and small structures (possibly speckles), or nuclear only. EGFP-Rev
protein localised to the nucleolus in all cell types examined. In all four
cell types EGFP-NΔNoLS/ORF57 localised predominately to the nucleolus,
with some cells also showing localisation to small nuclear structures.In all four cell types, EGFP-ORF57ΔNoLS/Rev localised to the nucleolus.
Vero cells were then selected for subsequent dynamic trafﬁcking
analysis to standardise data capture.
Viral proteins trafﬁc with different rates in the nucleolus
To compare the dynamic trafﬁcking of these viral proteins within
the nucleolus ﬂuorescence recovery after photo-bleaching (FRAP) and
ﬂuorescence loss in photo-bleaching (FLIP) were utilised. In the FRAP
experiments a deﬁned portion of the nucleolus was photo-bleached
and the relative ability of each protein to reﬁll this areawas compared.
In the FLIP experiments, cells were imaged which contained two
nucleoli, one of which was continuously photo-bleached, in order to
investigate protein trafﬁcking between the two. (Note that complete
photo-bleaching of the cell over the time course of the trafﬁcking
experiments described below indicated that no signiﬁcant de novo
synthesis of ﬂuorescent labelled proteins occurred).
Although other studies have investigated the dynamic trafﬁcking
of nucleolin, ﬁbrillarin and B23.1 under various metabolic conditions
and cell types (Andersen et al., 2005; Angelier et al., 2005; Dundr et al.,
2000; Phair and Misteli, 2000; You et al., 2008), these predominately
nucleolar proteins were used in this analysis to compare to the viral
proteins and also to provide a reference to previous work. In general
the trafﬁcking of nucleolar proteins can be classiﬁed into two broad
criteria — fast and slow, depending on their function (Hernandez-
Verdun, 2006). In this study 24 h post-transfection a deﬁned region of
the nucleolus was photo-bleached using FRAP and the time taken for
the nucleolar marker proteins (Fig. 5), viral proteins and chimeric viral
proteins (Fig. 6) to reﬁll this photo-bleached area was determined
Fig. 3. Live cell confocal imaging analysis of the sub-cellular localisation of (A) EGFP-N
and EYFP-N (false coloured red) proteins, (B) EFGP-ORF57 and BFP-ORF57 (false
coloured red) proteins, (C) EGFP-N and BFP-ORF57 (false coloured red) proteins, and (D)
EGFP-Rev and BFP-ORF57 (false coloured red) proteins, in Vero cells. Merged images are
also presented. The width of the marker is 10 μm. The nucleolus and cytoplasm are
indicated as No and Cyto, respectively.
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EGFP-ﬁbrillarin (t1/2=2.13±0.41 s) had recovery rates that were not
signiﬁcantly different from each other (P=0.22, signiﬁcant difference
P≤0.05). Whereas the recovery rate of EGFP-B23.1 (t1/2=7.69±3.68 s)
was signiﬁcantly different from both nucleolin and ﬁbrillarin (P=0.02
and 0.01, respectively; signiﬁcant difference P≤0.05). However,
recovery of these proteins was rapid, in line with previous observa-
tions (Chen and Huang, 2001; Dundr et al., 2000; Phair and Misteli,
2000). Proteins which are considered as having slower trafﬁcking
times, such as the ribosomal subunit proteins S5 and L9, generally give
t1/2 values of approximately 72 s (Chen and Huang, 2001).
Analysis of the trafﬁcking of viral proteins indicated that the
recovery of EGFP-N protein (t1/2=5.03±1.95 s) was not signiﬁcantly
different from EGFP-nucleolin and EGFP-B23.1 (P=0.06 and 0.11,
respectively; signiﬁcant difference P≤0.05), but was signiﬁcantly
different from EGFP-ﬁbrillarin (P=0.01, signiﬁcant difference P≤0.05).
However, the rate of recovery and hence an indication of the
trafﬁcking of EGFP-N protein within the nucleolus, is clearly compar-
able to the three nucleolar marker proteins used in this study.
Therefore it can be considered as fast, at least compared to the
recovery times previously described for nucleolin, ﬁbrillarin and
B23.1 (Chen and Huang, 2001; Dundr et al., 2000). In contrast, the
recovery of EGFP-Rev protein (t1/2=24.21±3.15 s) and EGFP-ORF57
(t1/2=42.97±7.29 s) protein were signiﬁcantly slower than the former
four proteins e.g. compared to EGFP-N protein (Pb0.00 for both,
signiﬁcant difference P≤0.05) and also from each other (Pb0.00,
signiﬁcant difference P≤0.05) and can be considered as slow. This is
in line with previous observations for the trafﬁcking of Rev protein
within the nucleolus (Daelemans et al., 2004).
The recovery rates observed with the trafﬁcking of viral proteins
in the nucleolus may not be attributed to size dependent diffusion
within the nucleolus, in that a smaller protein may be predicted to
trafﬁc quicker within the nucleolus. For example, the predicted
molecular weights of N, ORF57 and Rev monomeric proteins are
approximately 45, 48 and 15 kDa, respectively (excluding the EGFP
tag), yet the trafﬁcking of EGFP-Rev protein is slower than EGFP-N
protein, while the trafﬁcking of EGFP-N protein is faster than the
largest protein, EGFP-ORF57. This analysis is somewhat complicated
in that all three proteins have been reported to form multimers
(Chen et al., 2003; Daelemans et al., 2004; Malik and Clements,
2004). However, taken together our data suggests that similar to
cellular nucleolar proteins, different viral proteins (from diverse
viruses) can display different nucleolar trafﬁcking proﬁles. Indeed,
although conducted in different cell lines, the PRRSV N protein has
faster recovery rates than the IBV N protein and nucleolin,
ﬁbrillarin and B23.1 (You et al., 2008).
Dynamic trafﬁcking of viral proteins within the nucleolus is determined
by the viral NoLS
Interestingly, both the chimeric EGFP-ORF57ΔNoLS/Rev protein (t1/2=
38.50±9.78 s) and EGFP-NΔNoLS/ORF57 protein (t1/2=19.11±9.23 s) had
recovery times that were not signiﬁcantly different from the proteins
fromwhich their nucleolar targeting signals were derived (P=0.28 and
0.44, respectively; signiﬁcant difference P≤0.05). In contrast, the
recovery of these proteins within the nucleolus was signiﬁcantly
different from the parental EGFP-tagged wild type proteins e.g. EGFP-
ORF57ΔNoLS/Rev protein compared to EGFP-ORF57, P=0.01 (signiﬁcant
difference P≤0.05) and EGFP-NΔNoLS/ORF57 protein compared to EGFP-
N, Pb0.00 (signiﬁcant difference P≤0.05). This data suggested that the
heterologous NoLS alone could determine dynamic nucleolar trafﬁck-
ing of a protein.
This was further demonstrated when the diffusion coefﬁcient (D)
value of EGFP-nucleolin, EGFP-ﬁbrillarin, EGFP-B23.1, EGFP-N, EGFP-
Rev, EGFP-ORF57, EGFP-ORF57ΔNoLS/Rev and EGFP-NΔNoLS/ORF57 pro-
teins were calculated from the recovery curves (Phair and Misteli,
Fig. 4. Live cell confocal imaging analysis of the sub-cellular localisation of (A) EGFP-NΔNoLS/ORF57 and EYFP-N (false coloured red) proteins, (B) EGFP-NΔNoLS/ORF57 and BFP-ORF57
(false coloured red) proteins, (C) EGFP-ORF57ΔNoLS/Rev and BFP-ORF57 (false coloured red) proteins in Vero cells (arrows indicate one point of difference between samples, others are
visible in the merged image). The width of the marker is 10 μm. The nucleolus and nucleus are indicated as No and Nu, respectively.
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bleached area (Table 1). This data indicated that the chimeric viral
proteins had similar D values corresponding to the wild type protein
from which their NoLS was derived. For comparison EGFP-labelled
PRRSV N protein was shown to have a D value of 0.839 μm2/s (You et
al., 2008). This is approximately six times more mobile than EGFP-
labelled IBV N protein, and again indicated that viral proteins could
have variable mobility within the nucleolus.
The nucleolus is a dynamic structure and recent evidence
suggests it is continuously exchanging nucleolar proteins with thenucleoplasm (Matthews and Olson, 2006). To investigate if this
occurred with viral proteins and whether the NoLS was involved in
regulating this exchange, we performed FLIP experiments on cells
with two nucleoli which contained the ﬂuorescently tagged viral
protein. In this assay, a selected nucleolus was continually imaged
and photo-bleached for a period of 3 min and the ﬂuorescence
intensity of the non-bleached nucleolus was assessed. Rapid loss of
ﬂuorescence in the non-bleached nucleolus is suggestive of a
dynamic interchange of the tagged protein between the nucleo-
plasm and nucleolus. No reduction in ﬂuorescence intensity would
Fig. 5. FRAP analysis of EGFP-nucleolin, EGFP-ﬁbrillarin and EGFP-B23.1. Images were
sampled pre-bleach and post-bleach ﬁve times a second for 60 s. EGFP-fusion proteins
are false coloured to show their concentration using the ‘rainbow’ feature on the Zeiss
LSM imaging software, where red is high intensity and blue is low intensity. The
experiment was repeated ﬁve times and a representative image from each cell series is
shown for pre-bleach, immediately post-bleach (0 s), 10, 20, 30 and 60 s post-bleach.
The bleach area is denoted in the immediate post-bleach image (0 s), and the width of
the marker is 10 μm.
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neighbouring nuclei in all of the experiments (data not shown).
Comparison of the relative trafﬁcking between two nucleoli using
FLIP in general reﬂected the mobility data obtained in the FRAP
experiments. The three cellular nucleolar proteins examined were
rapidly lost from the non-bleached nucleolus, with greatly reduced
signal at 60 s (Fig. 8). This is similar to the data of Phair and Misteli
(2000), who found that if one nucleolus was continuously photo-
bleached then this resulted in the complete loss of nucleolin, ﬁbrillarin
and B23.1 from the other. Our data indicated that there was no generalcorrelation between rate of loss and whether the protein had a
nucleolar/nuclear rather than an exclusively nuclear distribution (e.g.
EGFP-nucleolin versus EGFP-B23.1). Of the viral proteins examined,
loss of ﬂuorescence from the unbleached nucleolus was not related
to the molecular weight of the protein, with EGFP-ORF57 having a
slower amount of loss compared to EGFP-Rev and EGFP-N, the latter
of which had the fastest amount of loss (Fig. 9). A possible
explanation for this observation may be due to the presence of a
pool of the viral protein in the nucleoplasm which is more readily
drawn on by the photo-bleached nucleoli, as observed with EGFP-
nucleolin and EGFP-ﬁbrillarin. Again, the chimeric proteins had loss
rates which were similar to the protein from which the NoLS was
derived. EGFP-NΔNoLS/ORF57 protein was retained in the non-photo-
bleached nucleolus similar to EGFP-ORF57 and EGFP-ORF57ΔNoLS/Rev
protein had a greater loss than EGFP-ORF57.
The data presented in this study suggested that viral NoLSs could
have a dual role in determining the localisation and trafﬁcking of a
protein within the nucleolus. This is supported by the use of chimeric
viral proteins which have their own NoLS mutated and a heterologous
NoLS inserted. These chimeric proteins have an altered localisation
pattern and trafﬁcking rate which overrides the wild type phenotype
and would appear to be dependent on the heterologous NoLS.
Interestingly substitution of the ORF57 NoLS with the Rev Protein
NoLS restored the viral RNA trafﬁcking function of ORF57 protein
(Boyne and Whitehouse, 2006).
Given that trafﬁcking of the viral and chimeric proteins may not
be related to their molecular weight, the different NoLSs may be
interacting with different cellular partners to promote differential
trafﬁcking and localisation of a protein within the nucleolus.
Within the nucleolus the two obvious candidates are interactions
with nucleolar proteins and/or RNA. Previous data has indicated
that N protein can interact with nucleolin and ﬁbrillarin (Chen et
al., 2002; Dove et al., 2006; Reed et al., 2006). Indeed the
trafﬁcking proﬁle of N protein, in this study is similar to nucleolin
and ﬁbrillarin. This suggests a protein:protein interaction with N
protein and a cellular nucleolar protein may be responsible for its
trafﬁcking. However, Rev protein has been shown to co-localise and
interact with B23.1 (Dundr et al., 1995; Li, 1997; Marasco et al.,
1994; Miyazaki et al., 1996) although the trafﬁcking proﬁles are
different. Similarly ORF57 can also associate with viral RNA and
other cellular protein which are found in the nucleolus (Boyne et
al., 2008; Williams et al., 2005). Likewise, although PRRSV N
protein has been shown to interact with ﬁbrillarin (Yoo et al., 2003)
the mobility of the two proteins within the nucleolus is different
(EGFP labelled PRRSV N protein had a D value of 0.839 μm2/s and
EGFP-labelled ﬁbrillarin had a D value of 0.278 μm2/s) (You et al.,
2008).
The speciﬁc trafﬁcking dynamics of virus proteins which localise to
the nucleolus may be important for function. Certainly, abolishing the
nucleolar localisation of viral proteins through mutation of speciﬁc
trafﬁcking signals is detrimental for virus biology (Huang et al., 2001;
Kim et al., 2007a, 2004, 2007b; Lee et al., 2006, 1998; Pei et al., 2008).
Disrupting the efﬁciency of nucleolar localisation of viral proteins
through the use of chimeric or mutated NoLSs may therefore be a way
of attenuating virus replication, whether as part of an antiviral
strategy or for the design of recombinant growth attenuated virus and
potential vaccine candidates.
Materials and methods
Cell culture
Vero, DF-1, HeLa and OMK cells were grown at 37°C with 5% CO2 in
Dulbecco's modiﬁed Eagles media (DMEM) supplemented with 10%
foetal calf serum and penicillin/streptomycin. 33 mm glass based tissue
culture dishes were seeded with 2×105 cells 24 h prior to transfection.
Fig. 6. FRAP analysis of EGFP, EGFP-N, EGFP-Rev, EGFP-ORF57, EGFP-ORF57ΔNoLS/Rev and EGFP-NΔNoLS/ORF57. Images were sampled pre-bleach and post-bleach ﬁve times a second for
60 s. EGFP-fusion proteins are false coloured to show their concentration using the ‘rainbow’ feature on the Zeiss LSM imaging software, where red is high intensity and blue is low
intensity. The experiment was repeated ﬁve times and a representative image from each cell series is shown for pre-bleach, immediately post-bleach (0 s), 10, 20, 30 and 60 s post-
bleach. The bleach area in the nucleolus is denoted in the immediate post-bleach image (0 s), and the width of the marker is 15 μm.
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The construction and use of pEGFP, pEGFP-nucleolin, pEGFP-
ﬁbrillarin, pEGFP-B23.1, pEGFP-N, pEGFP-ORF57, pBFP-ORF57,
pEGFP-HIV-Rev and EGFP-ORF57ΔNoRS/Rev have been described
previously (Boyne and Whitehouse, 2006; Goodwin et al., 1999;
Goodwin and Whitehouse, 2001; Reed et al., 2006; You et al., 2005).
pEGFP-NΔNoLS/ORF57 was constructed by amplifying the ORF 57
nucleolar targeting signal using PCR with forward primer 5′-
AAAGAATTCAAGCGACCCCGTATCAGC-3′ and reverse primer 5′-AAA-
GAATTCTGGCTTTCTGAAAGGCCT-3′, and sub-cloned into TOPO TA
vector pCR2.1. The ORF57 nucleolar targeting signal was isolated
using incorporated EcoRI restriction sites and inserted into EcoRI
digested pEGFP-NΔNoLS (in which the IBV N protein NoLS had been
disabled and therefore the protein did not localise to the nucleolus;
Reed et al., 2006). This produced an expression constructwhere the ORF
57NoLSwas C-terminal of EGFP andN-terminal of IBVNprotein. pEYFP-N was constructed by using pEGFP-N as the template for PCR. Primers
were designed to introduce a XhoI restriction site 5′ of the construct
(EdC1IBVN-fwd CCGCTCGAGATATGGCAAGCGGTAAAGCAGCTGGA) and
a SalI site 3′ of the construct (EdN1IBVN-rev CGGGTCGACATTCAAAGTT-
CATTCTCTCCTAGAGCTGC). PCR products were then puriﬁed and sub-
cloned into pCR-Blunt (Invitrogen) as per the manufacturer's instruc-
tions. DNAwasdigestedwithXhoI andSalI (NewEnglandBiolabs) before
being ligated into pEYFP-N1 (Clontech), which, when expressed,
produced full-length N protein fused to the N-terminus of EYFP. The
orientation of all inserts was conﬁrmed by sequencing and correct
expression by Western blot (data not shown).
Confocal imaging
Confocal images were captured on an LSM510 META microscope
(Carl Zeiss Ltd., Germany) equipped with a 40× and 63×, NA 1.4, oil
immersion lens. Pinholes were set to allow optical sections of 1 μm to be
Fig. 7. (A). FRAP analysis was performed on cells transfected with EGFP-tagged cellular
and viral proteins. The recovery curves are shown over a period of 2 min following a
photo-bleach period. Datawas normalized following the bleach period so that the initial
post-bleach was set at zero, and the ﬁnal intensity level was set at one. (B). Quantitative
analysis showing the relative half life recovery in seconds of GFP tagged cellular and
viral proteins within the nucleolus of transfected Vero cells.
Fig. 8. FLIP analysis of EGFP-nucleolin, EGFP-ﬁbrillarin and EGFP-B23.1. One nucleolus
was continuously photo-bleached (indicated by an arrow) and images were sampled at
0, 10, 20, 30 and 60 s. EGFP-fusion proteins are false coloured to show their
concentration using the ‘rainbow’ feature on the Zeiss LSM imaging software, where
red is high intensity and blue is low intensity. The experiment was repeated ﬁve times
and a representative image from each cell series is shown. The width of the marker is
10 μm.
199E. Emmott et al. / Virology 380 (2008) 191–202acquired. EGFP was excited with the 488 nm argon laser line running at
2% and emission was collected through a LP505 ﬁlter. All ﬂuorescence
was measured in the linear range as the detector is a photomultiplier,
and the range indicator was utilised to ensure no saturated pixels were
obtained on image capture. Images were averaged four times.
FRAP microscopy and data analysis
Cells were plated onto glass based 33 mm culture dishes,
transfected and imaged 24 h later on an inverted LSM 510 META
confocal microscope (Carl Zeiss, Herts, UK). Cells were maintained atTable 1
Expressed protein Diffusion coefﬁcient (D)
EGFP-nucleolin 0.257±0.143 μm2/s
EGFP-ﬁbrillarin 0.299±0.05 μm2/s
EGFP-B23.1 0.097±0.043 μm2/s
EGFP-N protein 0.138±0.047 μm2/s
EGFP-Rev protein 0.039±0.027 μm2/s
EGFP-ORF57 protein 0.017±0.006 μm2/s
EGFP-ORF57ΔNoLS/Rev 0.037±0.013 μm2/s
EGFP-NΔNoLS/ORF57 0.017±0.003 μm2/s37 °C with a heated stage throughout the experiments. For imaging
cell culture medium was exchanged for CO2 independent medium
(Gibco) to maintain cell homeostasis throughout the experiments. All
images were captured using a 63× objective and a digital zoom factor
of 4 within the software. EGFP was excited with the 488 nm laser line
delivered from a 30 mW argon laser running at 6.1 A and 1% power
output; these settings were established as causing no residual
background bleaching of the sample with the appropriate controls.
Photo-bleaching was performed on a deﬁned area of 12 pixels
squared, which equated to 20.16 μm2 area, within the nucleolus with
the 488 nm laser line at 100% power output for 100 iterations,
bleaching took approximately 1.2 s. Five imageswere collected prior to
the bleach and images were collected continually for up to 120 s
subsequently. Images are presented up to 60 s. Recovery of ﬂuores-
cencewas detailed using the ROIMeanmodule of the LSM510 software
and 12-bit data sets were exported into Microsoft Excel for analysis.
Data from 5–7 experiments were normalized so that the ﬁrst
time point following the bleach period was 0 and the ﬁnal
intensity measurement was 1 using the previously published
Fig. 9. FLIP analysis of EGFP-N, EGFP-Rev, EGFP-ORF57, EGFP-ORF57ΔNoLS/Rev and EGFP-NΔNoLS/ORF57. One nucleolus was continuously photo-bleached (indicated by an arrow) and
images were sampled at 0, 10, 20, 30 and 60 s. EGFP-fusion proteins are false coloured to show their concentration using the ‘rainbow’ feature on the Zeiss LSM imaging software,
where red is high intensity and blue is low intensity. The experiment was repeated ﬁve times and a representative image from each cell series is shown. The width of the marker is
10 μm.
200 E. Emmott et al. / Virology 380 (2008) 191–202equation It=(Xt−Y) / (Z−Y), where I is the intensity at time t, Y is the
intensity immediately after the photo-bleach and Z in the ﬁnal
intensity measurement (Stenoien et al., 2002). This allowed the time
to half ﬁnal recovery (t1/2) to be easily determined from the resultant
graphical data. Mean t1/2 are presented with standard deviations
determined using Microsoft Excel.
Diffusion coefﬁcient (D) values were calculated from the half
life recovery (t1/2) using the following diffusion equation D=(w2/4t1/
2)×0.88 where w is the width of the bleach area, approx 1.68 μm,
and a constant factor of 0.88 was used for a Gaussian beam proﬁle
(Axelrod et al., 1976). Data from 5 experiments were used per con-
struct and standard deviation was calculated in the usual manner
using Microsoft Excel.
FLIP microscopy
Transfected Vero cells were imaged in glass base dishes as outlined
above. Imaging and photo-bleaching were performed with the same
laser settings as detailed in the FRAP microscopy. In each FLIP
experiment a single cell nucleus was imaged 5 times followed by a
period of photo-bleaching for a total time of 3 min. Photo-bleaching
was performed on one nucleolus within the cell for 50 iterations
(mean bleach time 2.1 s). To ensure cell viability after laser power
submission, DIC images were taken of the cells before and after FLIPanalysis during preliminary experiments to establish photo-bleaching
conditions.
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